Patients with systemic lupus erythematosus (SLE) and type 2 diabetes, with and without lupus nephritis (LN), had a lower risk of serious cardiovascular and kidney diseases when they took GLP-1 ...

In patients with incomplete lupus erythematosus, hydroxychloroquine does not prevent progression to systemic lupus ...